9th Annual Biomarkers Congress

View Profile


Speaking/Presenting-Abstract/Poster at Mtg

Topic Authors / presenters Event name Event date
1. Genomic Approach to Drug Development   Vanderbilt-Ingram Cancer Center Research Retreat December, 2000
2. IgE Mediated Hypersensitivity Reaction to Cetuximab    Head and Neck Cancer Education Session at Eastern Cooperative Oncology Group Fall Meeting November, 2000
3. High Gene Copy Number of EGFR by FISH in HNSCC Head and Neck Cancer Education Session at Eastern Cooperative Oncology Group Fall Meeting November, 2000
4. New Developments in the Treatment of Head and Neck Cancer: the Promise of Individualized Therapy     Cancer Center Grand Round at the University of Pittsburgh October, 2000
5. The Biology of Head and Neck Cancer   Research Conference at Amgen Oncology Therapeutics October, 2000
6. Proteomics: Emerging Technology in Non-Small Cell Lung Cancer Research The 9th Annual Terry Fox and Chang Gung Memorial Hospital International Cancer Symposium October, 2000
7. Genomic Approach to Molecular Characterization of Head and Neck Cancer   Vanderbilt-Ingram Cancer Center Melanoma Conference October, 2000
8. Molecular Classification: Expression Signatures for Prognosis and Prediction of Treatment Response in Head and Neck Cancer      The 14th European Cancer Conference September, 2000
9. Discovery and Validation of Gene Expression Biomarkers in FFPE Tissues    Discovery 2 Diagnostics Conference September, 2000
10. The Promise of Individualized Therapy in Head and Neck Cancer Skin Disease Research Center Conference September, 2000
11. New Developments in Individualized Therapy for Head and Neck Cancer      Research Conference at the Karolinska Institutte September, 2000
12. The Promise of Individualized Therapy based on Genomic and Proteomic Profiles      Hematology/Oncology Grand Round at Memorial Sloan Kettering Cancer Center September, 2000
13. Immunological Aspects of Antibody-based Therapies in Cancer    European Society for Medical Oncology Congress, Satellite Symposium September, 2000
14. The Promise of Individualized Therapy in HNSCC    University of Texas, M.D. Anderson Cancer Center August, 2000
15. Gene Expression based Outcome Prediction in Head and Neck Cancer   Damon Runyon-Eli Lilly and Company Clinical Investigator Awardees Symposium August, 2000
16. Genomic and Proteomic Profiling of Head and Neck Cancer    The American Head & Neck Society 2006 Annual Meeting & Research workshop August, 2000
17. New Directions in Head and Neck Cancer Therapy Continuing Education Program at University of Alabama, Birmingham July, 2000
18. New Developments in the Treatment of Head and Neck Cancer: the Promise of Individualized Therapy    Medicine Grand Round at Vanderbilt University July, 2000
19. Translation of Genomics-based Biomarkers in Clinical Cancer Research AACR Molecular Biology in Clinical Oncology Workshop July, 2000
20. Implementation of Molecular Signatures to Clinical Trials: Strategic Plans within RTOG   Translational Research Program Committee meeting at Radiation Therapy Oncology Group Semi-Annual Meeting June, 2000
21. Proteomic Prediction of Clinical Benefit by EGFR TKIs in Pretreatment Peripheral Blood   Molecular Therapeutics Scientific Symposium at Eastern Cooperative Oncology Group Spring Meeting June, 2000
22. ImmunoCAP Anti-cetuximab IgE Assay and Study Findings   Cetuximab Hypersensitivity Reaction Investigators Meeting June, 2000
23. Application of Gene Expression Analyses for Survival Prediction in HNSCC Head and Neck Cancer Committee meeting at Radiation Therapy Oncology Group Semi-Annual Meeting June, 2000
24. Prediction of Recurrence-Free Survival based on Molecular Classification of HNSCC Head and Neck Cancer Education Session at Eastern Cooperative Oncology Group Spring Meeting June, 2000
25. Head and Neck Cancer: ASCO Review 2005    Post ASCO Review Symposium June, 2000
26. Raising the Bar for Biomarker Studies in Head and Neck Cancer   American Society of Clinical Oncology, Annual Meeting, Abstract Oral Presentation Discussant June, 2000
27. Human Papillomavirus in Head and Neck Cancer and Its Clinical Implications     Invited Lecture, Tokyo University Medical Center June, 2000
28. Application of Gene Expression Profiling in the Treatment of Head and Neck Cancer    Invited Lecture, Hokkaido University Medical Center June, 2000
29. Application of Gene Expression Profiling in the Treatment of Head and Neck Cancer      Invited Lecture, Hokkaido University Medical Center June, 2000
30. The Promise of Individualized Therapy based on Genomic and Proteomic Profiles      Keynote Speaker, The 33rd Japanese Head and Neck Cancer Society Annual Meeting June, 2000
31. Human Papillomavirus in Head and Neck Cancer and Its Clinical Implications     Invited Lecture, Kobe University Medical Center June, 2000
32. The Role of Host/Tumor Genetics in Cancer Treatment    American Society of Clinical Oncology, Annual Meeting, Poster Discussant May, 2000
33. Therapeutic Targets in HNSCC Head and Neck Cancer Education Session at Eastern Cooperative Oncology Group Spring Meeting May, 2000
34. Gene Expression based Outcome Prediction in Head and Neck Cancer    Damon Runyon Cancer Research Foundation April, 2000
35. New Developments in the Treatment of Head and Neck Cancer    Cancer Center Grand Round at the University of Calgary April, 2000
36. Cetuximab-related Hypersensitivity Reaction (HSR) associated with pre-existing cetuximab-specific IgE Antibody    Cetuximab HSR Investigators Meeting April, 2000
37. Targeted Agents for the Treatment of Head and Neck Cancer Vanderbilt-Ingram Cancer Center Affiliate Network Spring Meeting April, 2000
38. Molecular Characterization of Head and Neck Cancer and Its Clinical Applications   Louisiana Cancer Research Consortium Research Seminar April, 2000
39. Integrating Genomics and Proteomics to Clinical Trials The 3rd International Symposium on Targeted Anticancer Therapies March, 2000
40. The Promise of Individualized Therapy based on Genomic and Proteomic Profiles Scientific Symposium: The Best in Radiation Oncology March, 2000
41. Activated EGFR Signature in HNSCC The American Association for Cancer Research Special Conference in Cancer Research: Advances and Challenges in Aerodigestive Epithelial Cancers February, 2000
42. Molecular Classification of HNSCC   The 4th Annual Opinion Leader Consortium on Novel and Targeted Therapies for Head and Neck Cancer February, 2000
43. Application of Gene Expression Profiling in the Treatment of Head and Neck Cancer    International Conference on Innovative Approaches in Head and Neck Oncology February, 2000
44. Gene Expression Profiles as Markers of Aggressive Disease-EGFR as a Factor   Multidisciplinary Head & Neck Cancer Symposium January, 2000
45. Translation of Genomics- and Proteomics-based Biomarkers in Head and Neck Cancer The American Association for Cancer Research Annual Meeting: New Concepts in Organ Site Research, Recent Advances in Head and Neck Cancer January, 2000



Site wide Speaking/Presenting-Abstract/Poster at Mtg

No events found.
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.